By D. W. G. Kalani Tharanga, JadeTimes News
Celebrity Influence and the Black Market Surge
Semaglutide, the active ingredient in popular weight loss drugs like Ozempic and Wegovy, has gained notoriety for its effectiveness in tackling severe weight issues. However, its surge in demand, fueled by celebrity endorsements and success stories, has led to a dangerous black market for these slimming drugs. Investigations has revealed the alarming ease with which these illegal and often life threatening products can be acquired.
Vicky Boyd from Newcastle shared her harrowing experience with black market semaglutide. Looking forward to a holiday but battling severe insecurity about her weight, she sought a quick fix. Weighing 13 stone, she felt desperate and purchased semaglutide from a "friend of a friend." After self administering the injection, she quickly fell ill, experiencing severe symptoms that landed her in the hospital. "My body was riddled with toxins, my heart rate was over 200, and I had damaged my kidneys," she recounted. Despite receiving treatment, Vicky's health remains compromised, and she warns others against seeking similar quick fixes.
Similarly, another woman from Sunderland became violently ill after buying semaglutide through a similar informal network. Hospital tests revealed that the substance contained insulin and unknown compounds instead of semaglutide, posing severe health risks. These cases underscore the dangers of unregulated weight loss drugs circulating on the black market, often containing harmful substances.
Unregulated Sales and the Need for Stricter Oversight
The investigation also highlighted the unregulated sale of semaglutide through various channels, including beauty salons and social media platforms. A woman from Newcastle, who purchased semaglutide from a local beauty salon, experienced severe side effects and was rushed to the hospital. The salon owner, upon being confronted, claimed ignorance of the law and ceased sales. However, the widespread availability of such products indicates a larger issue of illegal distribution.
Social media platforms, particularly Facebook, have become hotspots for these transactions. Despite Meta's efforts to remove violating content, the sale of prescription drugs persists. Professor Oksana Pyzik from UCL School of Pharmacy emphasized the casual attitude towards Ozempic compared to other prescription medications. She stressed the need for updated laws and greater accountability for social media companies. "Buying a medicine from social media is gambling with your life," she warned, advocating for better public education on the risks involved.
Dr. Paul Evans, a GP from Gateshead, noted the spike in patient interest in Wegovy following media coverage. However, due to supply issues and regional unavailability, many turn to dangerous alternatives. The Department of Health and the Medicines and Healthcare products Regulatory Agency (MHRA) are working to curb illegal sales and ensure public safety. Dr. Alison Cave, MHRA's chief safety officer, urged the public to report illegal activities instead of risking their health with unverified medicines.
Vicky Boyd's husband, Peter, has shared her story widely on social media, warning others of the potential dangers. His post has resonated with many, prompting them to reveal similar experiences. "We were lucky," Peter said, "The next person might not be." The Boyd family's ordeal serves as a stark reminder of the risks associated with black market weight loss drugs and the need for caution and regulatory vigilance.
